LAM
TXG icon

LECAP Asset Management’s 10x Genomics TXG Stock Holding History

LECAP Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-61,470
Closed -$712K – 393
2025
Q2 		$712K Buy
+61,470
New +$560K 0.25% 159
2024
Q4 		– Sell
-38,829
Closed -$877K – 410
2024
Q3 		$877K Buy
+38,829
New +$803K 0.19% 198
2024
Q2 		– Sell
-14,115
Closed -$530K – 424
2024
Q1 		$530K Buy
14,115
+2,626
+23% +$115K 0.11% 256
2023
Q4 		$643K Buy
+11,489
New +$500K 0.23% 160

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LECAP Asset Management's TXG Position: Q3 2025 in Review

LECAP Asset Management sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 61,470 shares — an estimated $712K sold.

LECAP Asset Management first reported a position in TXG in Q4 2023 and held it in 4 quarters. The position peaked at $877K in Q3 2024. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • LECAP Asset Management reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • LECAP Asset Management sold 61,470 10x Genomics shares in Q3 2025, an estimated $712K.
  • LECAP Asset Management first reported a position in 10x Genomics in Q4 2023 and held it in 4 quarters.
  • LECAP Asset Management's 10x Genomics position peaked at $877K in Q3 2024.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on LECAP Asset Management's 13F filing for Q3 2025, filed 23 Oct 2025.